© 2007 Center for Pharmaceutical Learning
W.H.O. G.M.P. INSPECTION PERFORMA
DATE OF INSPECTING FIRM’S
REPRESENTATIVES
INSPECTION OFFICERS: PRESENT DURING
INSPECTION
FIRM’S NAME: PHONE NO. :
ADDRESS:
LICENCE NO.:
CATEGORIES OF DRUGS MANUFACTURED
AND PRODUCTION CAPACITY:
DETAILS OF EXPORT, IF UNDERTAKEN
ALREADY:
TECHNICAL PERSONNEL:
MANUFACTURING:
QUALITY CONTROL:
PRODUCTS TO BE CERTIFIED:
PRODUCTS LICENSED:
WHETHER SITEMASTER FILE SUBMITTED
IF YES, COMMENTS OF INSPECTING
OFFICER ON SITE MASTER FILE.
© 2007 Center for Pharmaceutical Learning
Complaint Yes/No Remark if non
complaint
1. PERSONNEL:
1.1 IS ORGANISATION CHART AVAILABLE:
1.2 ARE NO. OF PERSONNEL ADEQUATE:
1.3 NAME ,QUALIFICATION AND EXPERIENCE OF KEY
PERSONNEL(CHECK WITH SMF):
1.4 IS QUALIFICATION AND EXPERIENCE OF
PERSONNEL COMMENSURATE WITH JOB
DESCRIPTION:
1.5 IS MANAGERIAL RESPONCIBILITIES OF EACH
TECHNICAL PERSONNEL SPECIFIED IN WRITTING
WITH JOB DESCRIPTION:
1.6 CHECK WHETHER THERE ARE GAPS OR
UNEXPLAINED OVERLAP OF RESPONSIBILITIES
OF THE CONCERNED PERSONNEL:
2. TRAINING OF PERSONNEL:
2.1 IS WRITTEN PROGRAMME FOR TRAINING
AVAILABLE:
2.2 ARE ALL PERSONNEL TRAINED INITIALLY:
2.3 ARE PERIODICAL ASSESMENT RECORDS
AVAILABLE
2.4 IS SPECIAL PROGRAMME AVAILABLE FOR
PERSONNEL WORKING IN CLEAN AREAS AND
AREAS WHERE HIGHLY ACTIVE AND TOXIC
MATERIAL & HANDLED:
2.5 IS SOPs FOR TRAINING OF PERSONNEL
AVAILABLE:
3. PERSONNEL HYGIENE OF PERSONNEL:
3.1 ARE ALL PERSONNEL MEDICALLY EXAMINED
PRIOR TO = AND DURING EMPLOYMENT:
3.2 ARE THEY RESTRICTED , IF MEDICAL REASONS
DICTATE:
3.3 IS SOPs FOR CLOTHING AND HYGIENE
AVAILABLE:
© 2007 Center for Pharmaceutical Learning
3.4 ARE CLEAN UNIFORMS AND HAIR COVERING
CAPS USED:
3.5 CHECK NO. OF UNIFORMS PROVIDED. ARE
THEY ADEQUATE:
3.6 WHAT PROTECTIVE CLOTHING ARE PROVIDED
FOR VISITORS / OUTSIDE PERSONNEL
ENTERING IN PRODUCTION AREAS. ARE THEY
ADEQUATE:
4. PREMISES :
4.1 BRIEF DESCRIPTION OF BUILDING
4.2 IS DESIGNS AND CONSTRUCTED:
4.3 IS THE PREMISES COMPLY WITH SMF AND
SITUATED IN AN ENVIRONMENT WHICH CAUSED
MINIMUM RISK OF CONTAMINATION TO
MATERIALS OR PRODUCTS:
4.4 IS AREA PROVIDED COMMENSURATE WITH
PRODUCTION:
4.5 ARE NON MEDICAL PRODUCTS MANUFACTURED
IN THE PREMISES. IF YES, GIVE DETAILS:
4.6 ARE SOPs AVAILABLE FOR MAINTENANCE,
CLEANING AND SANITATION OF BUILDINGS,
PREMISES AND SURROUNDING
4.7 CHECK WHETHER THE AREA IS CLEANED AND
VALIDATED BEFORE STARTING STORING
/PROCESING /PACKING OPERATIONS:
4.8 IS ELECTRICAL SUPPLY,
LIGHTING,TEMPERATURE,HUMIDITY,AND
VENTILATION APPROPRIATE:
4.9 ARE ARRANGEMENT MADE FOR CONTROL OF
ENTRY OF RODENTS& BIRD
4.10 ARE FOLLOWING AREAS PROVIDED:
(A) SEPARATE REST ROOMS AND REFRESHMENT
ROOMS:
(B) SEPARATE CHANGING ROOMS AND TOILETS
FOR MALE AND FEMALE WORKERS:
(C) WORKSHOP IN A SEPARATE PLACE:
(D) ANIMAL HOUSES WITH SEPARATE ENTRY AND
AIR HANDLING UNIT:
5. STORAGE AREAS:
5.1 IS AREA SUFFICIENT FOR ORDERLY STORAGE
© 2007 Center for Pharmaceutical Learning
OF MATERIALS:
5.2 INDICATE AREAS FOR EACH CATEGORY AND
WHETHER BARRIERS ARE PROVIDED IF NOT,
EXPLAIN MODE OF SEGREGATION:
RAW MATERIALS:
QUARANTINE:
APPROVED:
REJECTED:
PACKING MATERIALS:
IS ACCESS TO QUARANTINE AREA
RESTRICTED:
5.4 ARE REJECTED GOODS MARKED AND STORED
SEPARATELY IN A SECURED AREA:
5.5 ARE RECORDS FOR ACTION TAKEN ON
REJECTED GOODS AVAILABLE:
5.6 ARE FACILITIES AVAILABLE FOR STORAGE IN
CONTROLLED TEMPERATURE/ HUMIDITY:
5.7 IS RECORD OF TEMPERATURE AND HUMIDITY
MAINTAINED:
5.8 ARE RECEIVING BAYS COVERED
5.9 ARE INCOMING MATERIALS CLEANED BEFORE
ENTRY TO STORAGE AREA:
5.10 IS SEPARATE SAMPLING AREA PROVIDED.IF ,
NOT HOW CONTAMINATION AND CROSS
CONTAMINATION IS PREVENTED:
5.11 ARE SENSITIVE MATERIALS/
HORMONES,BLACTUM, ANTIBIOTICS,
NARCOTICS,INFLAMMABLES, EXPLOSIVES
STORED IN SECURED AREA:
5.12 ARE PRINTED/CODED PACKING MATERIALS AND
CUT LABELS STORED IN SECURED AREA WITH
RESTRICTED ENTRY,AND WHETHER PACKING
MATERIALS LINE LABELS,CARTONS.LEAFLETS
ARE IN PIGEON HOLE, ALMIRAH:
5.13 IS DISPENSING AREA PROVIDED WITH DUST
© 2007 Center for Pharmaceutical Learning
CONTROL PROVISION:
5.14 DESCRIBE THE PRIMARY PACKING MATERIALS
STORAGE AREA:
6. PRODUCTION AREA:
6.1 ARE PRODUCTION AREAS FOR THE
FOLLOWINGS SEPARATED AND SELF CONTAIN.
DESCRIBE THE NATURE OF SEPARATION:
(A) BETA- LACTUM ANTIBIOTICS:
(B) HORMONES/CORTICOSTEROIDS
(C) OTHER DRUGS.
6.2 WHETHER THE ACCESS TO PRODUCTION AREA
RESTRICTED TO AUTHORISED PERSONNEL:
6.3 ARE WALLS, FLOORS AND CEILING SMOOTH AND
FREE FROM CRACKS:
6.4 IS THE PRODUCTION AREA WELL-LIT:
6.5 HOW CROSS CONTAMINATION OF STARTING
MATERIAL OR OF A PRODUCT BY ANOTHER
MATERIAL OR PRODUCT IS PREVENTED:
6.6 IS THE LAY OUT OF MANUFACTURING DIVISION
OF EACH CATEGORY OF DOSAGE FORM IN
LOGICAL SEQUENCE. IF NOT, GIVE DETAILS
WITH REFERENCE TO FLOOR PLAN:
6.7 IS WORKING SPACE ADEQUATE AND ATLEAST
ONE METER PROVIDED AROUND FOR EACH
EQUIPMENT:
6.8 ARE SERVICE LINES, LIGHT FITTINGS
CONCEALED AND FLUSHED TO THE SURFACE
OR MADE ACCESSIBLE FROM OUTSIDE. LOOK
FOR PROTRUDING SURFACE AND SPECIFY:
6.9 ARE DRAINE PROVIDED WITH TRAPS TO AVOID
BACK FLOW
6.10 ARE DRAINS CLEANED AND DISINFECTED
PERIODICALLY. CHECK RECORDS:
6.11 IS PRODUCTION AREA PROVIDED WITH PROPER
VENTILATION WITH AIRCONTROL FACILITIES
(FILTRATION, TEMPERATURE AND
HUMIDITY).ARE RECORDS MAINTAINED
© 2007 Center for Pharmaceutical Learning
THEREOF.
6.12 ARE LOCKERS PROVIDED FOR STORAGE OF
TOOLS AND PARTS:
6.13 ARE PACKAGING AND VISUAL INSPECTION
AREAS DESIGNED TO FACILITATE SEGREGATION
FOR EACH WORK LINE:
6.14 ARE EQUIPMENTS:
(A) LOCATED IN LOGICAL SEQUENCE (GIVE
BRIEF DESCRIPTION):
(B) DESIGNED, CONSTRUCTED TO SUIT THE
PURPOSE:
(C) PERMIT EFFECTIVE CLEANING:
(D) CLEANED BETWEEN BATCH OPERATION
AND RECORDED.CHECK RECORDS:
(E) CALLED TO INDICATE THEIR STATUS:
6.15 ARE SERVICE LINES PAINTED TO INDICATE THE
CONTENTS AND FLOW. RECORDS THE ORDER
SCHEME:
6.16 ARE BALANCES AND MEASURING EQUIPMENTS
CALIBRATED PERIODICALLY.CHECK RECORDS
AND PERIODICITY:
6.17 ARE WEIGHING EQUIPMENTS AND MEASURING
EQUIPMENTS OF APPROPRIATE RANGE AND
PRECISION AVAILABLE. CHECK CAPACITY OF
THE EQUIPMENT VIS-À-VIS BATCH SIZES OF
PRODUCTION:
6.18 CHECK THE TYPE OF WASHING AND CLEANING
EQUIPMENTS IN PRODUCTION AREA.(PARTICLE
GENERATING EQUIPMENTS SHOULD NOT BE
USED):
6.19 HOW DEFECTIVE EQUIPMENTS ARE
SEGREGATED:
7. MATERIALS:
7.1 IS SEGREGATION IS LOTWISE AND STOCK
ROTATION BY FIFO ADOPTED:
7.2 DOES PURCHASE DEPARTMENT STAFF
KNOWLEDGEABLE ABOUT THE PRODUCTS AND
MATERIALS:
7.3 HOW SUPPLIERS ARE SELECTED:
7.4 ARE SUPPLIERS EVALUATED AND APPROVED
AND THEIR NAME INCLUDED IN SPECIFICATION:
© 2007 Center for Pharmaceutical Learning
7.5 ARE PURCHASES MADE DIRECTLY FROM
PRODUCERS:
7.6 ARE MATERIALS CHECKED FOR INTEGRITY AND
CONFORMITY WITH ORDER ON RECEIPT:
7.7 IS DAMAGE RECORDED AND REPORTED TO
QUALITY CONTROL:
7.8 DO THE LABELS SHOW B.NO, NAME, C.R.NO. ,
STATUS,EXPIRY DATE , RETEST DATE
ETC.(COLLECT) SAMPLE OF INHOUSE LABELS):
7.9 IS COLOUR CODING SYSTEM USED TO INDICATE
STATUS:
7.10 ARE SAMPLE CONTAINERS IDENTIFIED AND
RELEASED:
7.11 ARE WRITTEN PRODUCERS FOR SAMPLING AND
DISPENSING AVAILABLE. COMPARE SOPs WITH
ACTUAL PRACTICE:
7.12 IS SAMPLING AND DISPENSING DONE BY
DESIGNATED PERSONS:
7.13 IS EACH DISPENSING CHECKED AND
RECORDED.
7.14 IS ADEQUATE STORAGE AREA FOR FINISHED
GOODS PROVIDED:
7.15 IS ADEQUATE AREA FOR RECALLED/RETURNED
PRODUCTS PROVIDED:
7.16 ARE PACKING MATERIALS CHECKED ON
DELIVERY AND ASSIGNED A SPECIFIC
REFERENCE NUMBER:
7.17 HOW THE WASTE MATERIALS FROM
STORE,PRODUCTION, QUALITYCONTROL
DISPOSED OFF:
7.18 IS THERE ACCUMULATION OF WASTE MATERIAL
AT ANY PART OF THE STORAGE/
PRODUCTION/Q.C.AREA:
8. DOCUMENTATION:
8.1 ARE ALL DOCUMENTS PREPARED AND
REVIEWED BY COMPETENT PERSONNEL
APPROVED AND SIGNED BY AUTHORISED
PERSONNEL:
8.2 ARE ALL DOCUMENTS PERIODICALLY REVISED:
8.3 ARE THE DOCUMENTS UNAMBIGUOUS CLEAR
EASY FOR REPRODUCTION AND EASY TO
CHECK:
© 2007 Center for Pharmaceutical Learning
8.4 IS THERE ANY ALTERATIONS, IN ENTRY MADE. IF
YES, ARE ALTERATIONS CLEAR, LEGIBLE AND
INITIALLED(OVER WRITING IS NOT PERMITTED):
8.5 ARE THE FOLLOWING DOCUMENTS AVAILABLE
WITH NECESSARY DETAILS:
(A) TESTING PROCEDURES FOR STARTING
MATERIALS, INTERMEDIATE PRODUCTS
AND FINISHED PRODUCTS,PACKING
MATERIALS:
(B) VALIDATION OF TESTING PROCEDURE:
(C) MASTER FORMULA CARD(COLLECT
SPECIMEN):
(D) PACKAGING INSTRUCTION (COLLECT
SPECIMEN):
(E) BATCH PROCESSING CARDS INCLUDING
INPROCESS CONTROLS.(COLLECT
SPECIMEN):
(F) BATCH PACKAGING CARD (COLLECT
SPECIMEN):
(G) REFERENCE STANDARDS:
(H) DISPOSAL RECORD OF OUTDATED
PRIMARY AND PRINTED PACKING
MATERIALS:
(I) RELEASE RECORDS:
(J) DISTRIBUTION RECORDS.(WITH WHAT
LEVEL):
(K) COMPARE MASTER FORMULA CARD WITH
© 2007 Center for Pharmaceutical Learning
ACTUAL PRACTICE:
8.6 ARE ALL RECORDS AND ASSOCIATED SOPs
RETAINED UPTO ONE YEAR AFTER EXPIRY OF
FINISHED PRODUCT:
8.7 ARE STANDARD OPERATING PROCEDURES FOR
THE FOLLOWING OPERATIONS AVAILABLE:
(A) RECEIPT MATERIALS:
(B) ENVIRONMENTAL MONITORING:
(C) INTERNAL LABELLING , QUARANTINE AND
STORAGE OF MATERIALS:
(D) EACH INSTRUMENT AND EQUIPMENT IN
THEIR PREXIMITY:
(E) EQUIPMENT ASSEMBLY AND VALIDATION:
(F) SAMPLING(RAW MATERIALS AND FINISHED
PRODUCTS):
(G) DISPENSING (RAW MATERIALS AND
PACKING MATERIALS):
(H) BATCH NUMBERING SYSTEM:
(I) RELEASE OR REJECTION:
(J) LOG BOOK FOR EACH EQUOPMENT AND
INSTRUMENT:
(K) SANITATION AND CLEANING OF PREMISES
AND EQUIPMENT:
(L) SANITATION OF PIPES CARRYING
DISTILLED/DEIONISED WATER:
© 2007 Center for Pharmaceutical Learning
(M)RECOVERY FROM REJECTED PRODUCTS:
(N) DISPOSAL/REUSE OF RETURNED GOODS:
(O) PEST CONTROL:
(P) ANALYTICAL APPARATUS AND
CALIBRATION:
(Q) COMPLAINTS,RECALLS AND RETURNS:
(R) COMPARE SOPs WITH ACTUAL PRACTICE:
9. PRODUCTION:
9.1 IS THERE ANY DEVIATION FROM SOPs
MANUFACTURING PROCEDURES:
9.2 IS YIELD CHECKED AT EACH STAGE:
9.3 IS MORE THAN ONE PRODUCT PROCESSED IN
THE SAME ROOM:
9.4 ARE EQUIPMENTS AND ROOMS LABELLED TO
INDICATE THE OPERATION IN PROGRESS:
9.5 IS ANY NON MEDICAL PRODUCT PRODUCED.
SPECIFY THE DETAILS:
9.6 IS THERE PROVISION FOR INPROCESS
CONTROLS IN THE PRODUCTION AREA(MUST
NOT EFFECT THE QUALITY OF THE PRIODUCTS
MANUFACTURED):
9.7 IS THERE PROVISION FOR DUST COLLECTION
WHERE DRY MATERIALS ARE HANDLED:
9.8 IS PERIODICAL MICROBIAL MONITORING OF
PRODUCTION AREAS OF SUCEPTIBLE PRODUCTS
CONDUCTED:
9.9 WAS THE AREA BEING CLEANED BEFORE
STARTING EVERY BATCH:
9.10 ARE PIPES CARRYING DISTILLED/DEIONISED
WATER SANITIZED ACCORDING TO PROCEDURE
WHICH INDICATE LIMITS FOR MICROBIAL
CONTAMINATION AND MEASURES TO BE TAKEN:
9.11 WAS ANY BATCH REPROCESSED FROM
© 2007 Center for Pharmaceutical Learning
REJECTED PRODUCTS:
9.12 WAS ANY BATCH RETURNED HAS BEEN
CONVERTED FOR RESALE , RELABELLING OR
BULKING:
10. PACKAGING:
10.1 IS THERE ADEQUATE SEPARATION OF PACKING
LINES TO PREVENT ANY MIX-UP:
10.2 IS EACH PACKAGING LINE IDENTIFIED WITH
PRODUCT NAME, BATCH NO. AND PACKAGING
SIZE:
10.3 IS ONLY ONE PRODUCT, BATCH AND PACKAGING
SIZE ON A LINE AT ANY GIVEN TIME:
10.4 IS LINE CLEARED BEFORE EACH BATCH
OPERATION,CERTIFIED AND RECORDED:
10.5 DOES PACKING QUICKLY FOLLOWS THE FILLING
AND SEALING:
10.6 ARE ALL CODED PACKING MATERIALS VERIFIED
BEFORE USE.
10.7 IS RECONCILATION OF PACKING MATERIALS
USED VIS-À-VIS PRODUCT RECORDED:
10.8 IS ON LINE COTROL PROCEDURE DURING
PACKING AVAILABLE:
11. QUALITY CONTROL:
11.1 HOW FAR THE HEAD OF QUALITY CONTROL
AND PRODUCTION ARE INDEPENDENT OF EACH
OTHER:
11.2 ARE ALL THE PROCEDURES OF
DOCUMEBNTED:
11.3 IS SAMPLING PROCEDURE ADEQUATE:
11.4 DO THE LABEL ON SAMPLE CONTAINER, SHOW
BATCH NO. , NAME,CONTAINER NO., DATE OF
SAMPLING AND PERSON WHO SAMPLED:
11.5 IS IDENTIFY TEST DONE ON EACH CONTAINER
OF STARTING MATERIALS:
11.6 ARE ANALYTICAL RECORDS OF EACH BATCH
OF THE RAW MATERIALS,INTERMEDIATES AND
FINISHED PRODUCTS AVAILABLE WITH WORK
SHEETS:
11.7 ARE PRODUCTION RECORDS REVIEWED:
11.8 ARE ALL RETENTION SAMPLES KEPT FOR ONE
YEAR AFTER EXPIRY DATE AND OTHER
© 2007 Center for Pharmaceutical Learning
STARTING MATERIALS FOR A MINIMUM OF TWO
YEARS:
11.9 IS PROGRAMME FOR STABILITY TESTING OF
STARTING MATERIALS AND FINISHED
PRODUCTS AVAILABLE:
11.10 IS STABILITY TESTING CONDUCTED PRIOR TO
MARKETING AND AFTER CHANGE OF PROCESS
EQUIPMENT,PACKING MATERIALS:
11.11 IS QUALITY CONTROL LAB SEPARATE FROM
PRODUCTION AREA:
11.12 ARE BIOLOGICAL AND MICROBIOLOGICAL
TESTING AREAS SEPARATE FROM EACH
OTHER,AND DO THEY HAVE SEPARATE AIR
HANDLING FACILITIES:
11.13 IS INSTRUMENT ROOM SEPARATE:
11.14 IS DESIGN OF LAB SUITABLE WITH ADEQUATE
SPACE,VENTILATION AND FOR PREVENTION OF
FUMES:
11.15 ARE RECORDS OF SERVICE AND CALIBRATION
OF INSTRUMENT AVAILABLE:
11.16 ARE APPROPRIATE SAMPLING EQUIPMENT
AVAILABLE AND STARTED SEPARATELY:
11.17 ARE INSTRUMENTS CHECKED DAILY OR PRIOR
TO USE:
11.18 ARE DATE OF CALIBRATION , SERVICE ,AND
DATE WHEN RECALIBRATION DUE INDICATED:
11.19 ARE THE REAGENTS PREPARED ACCORDING
TO WRITTEN PROCEDURES AND LABELLED
APPROPRIATELY:
11.20 ARE REFERENCE STANDARDS AVAILABLE
CORRESPOND TO THE MATERIALS ANALYSED:
11.21 IS ADEQUATE STORAGE SPACE (IF NECESSARY
WITH COOLING) AND RECORDS ARE AVAILABLE
FOR REFERENCE STANDARDS AND
REFERENCE SAMPLES. CHECK THE MODE OF
STORAGE OF REFERENCE STANDARDS:
11.22 ARE WORKING STANDARDS CHECKED AT
REGULAR INTERVALS:
11.23 ARE THE LABELS OF REF. STANDARDS
INDICATE NAME, DATE OF MFG. DATE OF
EXPIRY,CONCENTRATION AND DATE OF
CLOSURE IS FIRST OPENED AND STORAGE
CONDITIONS:
© 2007 Center for Pharmaceutical Learning
11.24 ARE THE LABEL OF REAGENTS PREPARED
SHOW CONCENTRATION , STANDARDISATION
FACTOR, SELF- LIFE,STANDARDISATION DATE
,STORAGE CONDITION AND SIGNATURE OF THE
PERSON PREPARES THE REAGENTS:
11.25 ARE POSITIVE AND NEGATIVE CONTROLS USED
TO TEST SUITABILITY OF CULTURE MEDIA:
11.26 ARE STABILITY STUDIES CONDUCTED BEFORE
ASSIGNING SHELF LIFE AND IS IT PERIODICALL
REVIEWED, AND GIVE DETAILS:
12. SELF INSPECTION:
GIVE DETAILS OF NAMES,
QUALIFICATION AND BACKGROUND
OF THE MEMBERS OF SELF
INSPECTION TEAM:
12.1 INTERVAL PERIOD BETWEEN SELF
INSPECTIONS:
12.2 DOES SELF INSPECTION REPORT CONTAINS
COMMENTS ON:
(A) PERSONNEL:
(B) PREMISES:
(C) MAINTENANCE OF BUILDING AND
EQUIPMENT:
(D) STORAGE:
(E) EQUIPMENT:
(F) PRODUCTION AND INPROCESS
CONTROL:
(G)QUALITY CONTROL:
(H) DOCUMENTATION:
© 2007 Center for Pharmaceutical Learning
(I) SANITATION AND HYGIENE:
(J) VALIDATION PROCEDURE /
PROGRAMMES:
(K) CALIBRATION OF INSTRUMENTS:
(L) RECALL PROCEDURES:
(M)LABELS CONTROL:
(N) COMPLAINTS:
(O)CORRECTIVE ACTION ON PREVIOUS
REPORTS:
13 RECALL PROCEDURE :
EXPLAIN PROCEDURE ADOPTED FOR RECALL
OF PRODUCTS:
14 QUALITY AUDIT SYSTEM :
(BRIEF RESPONSIBILITIES
REMARKS:
1.1 IS ORGANISATION CHART
AVAILABLE:
1.2 ARE NO. OF PERSONNEL
ADEQUATE:
1.3 NAME ,QUALIFICATION AND
EXPERIENCE OF KEY
PERSONNEL(CHECK WITH SMF):
1.4 IS QUALIFICATION AND
EXPERIENCE OF PERSONNEL
COMMENSURATE WITH JOB
DESCRIPTION:
1.5 IS MANAGERIAL
RESPONCIBILITIES OF EACH
© 2007 Center for Pharmaceutical Learning
TECHNICAL PERSONNEL
SPECIFIED IN WRITTING WITH
JOB DESCRIPTION:
1.6 CHECK WHETHER THERE ARE
GAPS OR UNEXPLAINED
OVERLAP OF RESPONSIBILITIES
OF THE CONCERNED
PERSONNEL:
2. TRAINING OF PERSONNEL:
2.1 IS WRITTEN PROGRAMME FOR
TRAINING AVAILABLE:
2.2 ARE ALL PERSONNEL TRAINED
INITIALLY:
2.3 ARE PERIODICAL ASSESMENT
RECORDS AVAILABLE
2.4 IS SPECIAL PROGRAMME
AVAILABLE FOR PERSONNEL
WORKING IN CLEAN AREAS
AND AREAS WHERE HIGHLY
ACTIVE AND TOXIC MATERIAL
& HANDLED:
2.5 IS SOPs FOR TRAINING OF
PERSONNEL AVAILABLE:
3. PERSONNEL HYGIENE OF PERSONNEL:
3.1 ARE ALL PERSONNEL
MEDICALLY EXAMINED PRIOR TO
= AND DURING EMPLOYMENT:
3.2 ARE THEY RESTRICTED , IF
MEDICAL REASONS DICTATE:
3.3 IS SOPs FOR CLOTHING AND
HYGIENE AVAILABLE:
3.4 ARE CLEAN UNIFORMS AND HAIR
COVERING CAPS USED:
3.5 CHECK NO. OF UNIFORMS
© 2007 Center for Pharmaceutical Learning
PROVIDED. ARE THEY
ADEQUATE:
3.6 WHAT PROTECTIVE CLOTHING
ARE PROVIDED FOR VISITORS /
OUTSIDE PERSONNEL ENTERING
IN PRODUCTION AREAS. ARE
THEY ADEQUATE:
6. PREMISES :
4.1 BRIEF DESCRIPTION OF BUILDING
4.2 IS DESIGNS AND CONSTRUCTED:
4.3 IS THE PREMISES COMPLY WITH SMF
AND SITUATED IN AN ENVIRONMENT
WHICH CAUSED MINIMUM RISK OF
CONTAMINATION TO MATERIALS OR
PRODUCTS:
4.4 IS AREA PROVIDED COMMENSURATE
WITH PRODUCTION:
4.5 ARE NON MEDICAL PRODUCTS
MANUFACTURED IN THE PREMISES. IF
YES, GIVE DETAILS:
4.6 ARE SOPs AVAILABLE FOR
MAINTENANCE, CLEANING AND
SANITATION OF BUILDINGS, PREMISES
AND SURROUNDING
4.7 CHECK WHETHER THE AREA IS CLEANED
AND VALIDATED BEFORE STARTING
STORING /PROCESING /PACKING
OPERATIONS:
4.8 IS ELECTRICAL SUPPLY,
LIGHTING,TEMPERATURE,HUMIDITY,AND
VENTILATION APPROPRIATE:
4.9 ARE ARRANGEMENT MADE FOR
CONTROL OF ENTRY OF RODENTS& BIRD
4.10 ARE FOLLOWING AREAS PROVIDED:
(A) SEPARATE REST ROOMS AND
REFRESHMENT ROOMS:
(B) SEPARATE CHANGING ROOMS
AND TOILETS FOR MALE AND
© 2007 Center for Pharmaceutical Learning
FEMALE WORKERS:
(C) WORKSHOP IN A SEPARATE
PLACE:
(D) ANIMAL HOUSES WITH
SEPARATE ENTRY AND AIR
HANDLING UNIT:
7. STORAGE AREAS:
5.1 IS AREA SUFFICIENT FOR
ORDERLY STORAGE OF
MATERIALS:
5.2 INDICATE AREAS FOR EACH
CATEGORY AND WHETHER
BARRIERS ARE PROVIDED IF
NOT, EXPLAIN MODE OF
SEGREGATION:
RAW MATERIALS:
QUARANTINE:
APPROVED:
REJECTED:
PACKING MATERIALS:
IS ACCESS TO QUARANTINE
AREA RESTRICTED:
5.4 ARE REJECTED GOODS
MARKED AND STORED
SEPARATELY IN A SECURED
AREA:
5.5 ARE RECORDS FOR ACTION
TAKEN ON REJECTED GOODS
AVAILABLE:
5.6 ARE FACILITIES AVAILABLE
FOR STORAGE IN
© 2007 Center for Pharmaceutical Learning
CONTROLLED TEMPERATURE/
HUMIDITY:
5.7 IS RECORD OF TEMPERATURE
AND HUMIDITY MAINTAINED:
5.8 ARE RECEIVING BAYS
COVERED
5.9 ARE INCOMING MATERIALS
CLEANED BEFORE ENTRY TO
STORAGE AREA:
5.10 IS SEPARATE SAMPLING AREA
PROVIDED.IF , NOT HOW
CONTAMINATION AND CROSS
CONTAMINATION IS
PREVENTED:
5.11 ARE SENSITIVE MATERIALS/
HORMONES,BLACTUM,
ANTIBIOTICS,
NARCOTICS,INFLAMMABLES,
EXPLOSIVES STORED IN
SECURED AREA:
5.12 ARE PRINTED/CODED
PACKING MATERIALS AND
CUT LABELS STORED IN
SECURED AREA WITH
RESTRICTED ENTRY,AND
WHETHER PACKING
MATERIALS LINE
LABELS,CARTONS.LEAFLETS
ARE IN PIGEON HOLE,
ALMIRAH:
5.13 IS DISPENSING AREA
PROVIDED WITH DUST
CONTROL PROVISION:
5.14 DESCRIBE THE PRIMARY
PACKING MATERIALS
STORAGE AREA:
7. PRODUCTION AREA:
© 2007 Center for Pharmaceutical Learning
6.1 ARE PRODUCTION AREAS FOR THE
FOLLOWINGS SEPARATED AND SELF
CONTAIN. DESCRIBE THE NATURE OF
SEPARATION:
(D) BETA- LACTUM ANTIBIOTICS:
(E) HORMONES/CORTICOSTEROIDS
(F) OTHER DRUGS.
6.2 WHETHER THE ACCESS TO
PRODUCTION AREA RESTRICTED TO
AUTHORISED PERSONNEL:
6.3 ARE WALLS, FLOORS AND CEILING
SMOOTH AND FREE FROM CRACKS:
6.4 IS THE PRODUCTION AREA WELL-LIT:
6.5 HOW CROSS CONTAMINATION
OF STARTING MATERIAL OR
OF A PRODUCT BY ANOTHER
MATERIAL OR PRODUCT IS
PREVENTED:
6.6 IS THE LAY OUT OF
MANUFACTURING DIVISION
OF EACH CATEGORY OF
DOSAGE FORM IN LOGICAL
SEQUENCE. IF NOT, GIVE
DETAILS WITH REFERENCE TO
FLOOR PLAN:
6.7 IS WORKING SPACE
ADEQUATE AND ATLEAST
ONE METER PROVIDED
AROUND FOR EACH
EQUIPMENT:
6.8 ARE SERVICE LINES, LIGHT
FITTINGS CONCEALED AND
FLUSHED TO THE SURFACE OR
MADE ACCESSIBLE FROM
OUTSIDE. LOOK FOR
PROTRUDING SURFACE AND
SPECIFY:
6.9 ARE DRAINE PROVIDED WITH
© 2007 Center for Pharmaceutical Learning
TRAPS TO AVOID BACK FLOW
6.10 ARE DRAINS CLEANED AND
DISINFECTED PERIODICALLY.
CHECK RECORDS:
6.11 IS PRODUCTION AREA
PROVIDED WITH PROPER
VENTILATION WITH
AIRCONTROL FACILITIES
(FILTRATION, TEMPERATURE
AND HUMIDITY).ARE
RECORDS MAINTAINED
THEREOF.
6.12 ARE LOCKERS PROVIDED FOR
STORAGE OF TOOLS AND
PARTS:
6.13 ARE PACKAGING AND VISUAL
INSPECTION AREAS DESIGNED
TO FACILITATE SEGREGATION
FOR EACH WORK LINE:
6.14 ARE EQUIPMENTS:
(F) LOCATED IN LOGICAL
SEQUENCE (GIVE BRIEF
DESCRIPTION):
(G) DESIGNED,
CONSTRUCTED TO SUIT
THE PURPOSE:
(H) PERMIT EFFECTIVE
CLEANING:
(I) CLEANED BETWEEN
BATCH OPERATION AND
RECORDED.CHECK
RECORDS:
(J) CALLED TO INDICATE
THEIR STATUS:
6.15 ARE SERVICE LINES PAINTED
TO INDICATE THE CONTENTS
AND FLOW. RECORDS THE
ORDER SCHEME:
6.16 ARE BALANCES AND
© 2007 Center for Pharmaceutical Learning
MEASURING EQUIPMENTS
CALIBRATED
PERIODICALLY.CHECK
RECORDS AND PERIODICITY:
6.17 ARE WEIGHING EQUIPMENTS
AND MEASURING
EQUIPMENTS OF APPROPRIATE
RANGE AND PRECISION
AVAILABLE. CHECK
CAPACITY OF THE EQUIPMENT
VIS-À-VIS BATCH SIZES OF
PRODUCTION:
6.18 CHECK THE TYPE OF WASHING
AND CLEANING EQUIPMENTS
IN PRODUCTION
AREA.(PARTICLE GENERATING
EQUIPMENTS SHOULD NOT BE
USED):
6.19 HOW DEFECTIVE EQUIPMENTS
ARE SEGREGATED:
8. MATERIALS:
7.1 IS SEGREGATION IS LOTWISE
AND STOCK ROTATION BY
FIFO ADOPTED:
7.2 DOES PURCHASE
DEPARTMENT STAFF
KNOWLEDGEABLE ABOUT
THE PRODUCTS AND
MATERIALS:
7.3 HOW SUPPLIERS ARE
SELECTED:
7.4 ARE SUPPLIERS EVALUATED
AND APPROVED AND THEIR
NAME INCLUDED IN
SPECIFICATION:
7.5 ARE PURCHASES MADE
DIRECTLY FROM PRODUCERS:
7.6 ARE MATERIALS CHECKED
FOR INTEGRITY AND
CONFORMITY WITH ORDER ON
RECEIPT:
© 2007 Center for Pharmaceutical Learning
7.7 IS DAMAGE RECORDED AND
REPORTED TO QUALITY
CONTROL:
7.8 DO THE LABELS SHOW B.NO,
NAME, C.R.NO. ,
STATUS,EXPIRY DATE ,
RETEST DATE ETC.(COLLECT)
SAMPLE OF INHOUSE LABELS):
7.9 IS COLOUR CODING SYSTEM
USED TO INDICATE STATUS:
7.10 ARE SAMPLE CONTAINERS
IDENTIFIED AND RELEASED:
7.11 ARE WRITTEN PRODUCERS
FOR SAMPLING AND
DISPENSING AVAILABLE.
COMPARE SOPs WITH ACTUAL
PRACTICE:
7.12 IS SAMPLING AND DISPENSING
DONE BY DESIGNATED
PERSONS:
7.13 IS EACH DISPENSING
CHECKED AND RECORDED.
7.14 IS ADEQUATE STORAGE AREA
FOR FINISHED GOODS
PROVIDED:
7.15 IS ADEQUATE AREA FOR
RECALLED/RETURNED
PRODUCTS PROVIDED:
7.16 ARE PACKING MATERIALS
CHECKED ON DELIVERY AND
ASSIGNED A SPECIFIC
REFERENCE NUMBER:
7.17 HOW THE WASTE MATERIALS
FROM STORE,PRODUCTION,
QUALITYCONTROL DISPOSED
OFF:
7.18 IS THERE ACCUMULATION OF
WASTE MATERIAL AT ANY
PART OF THE STORAGE/
PRODUCTION/Q.C.AREA:
© 2007 Center for Pharmaceutical Learning
9. DOCUMENTATION:
8.1 ARE ALL DOCUMENTS
PREPARED AND REVIEWED BY
COMPETENT PERSONNEL
APPROVED AND SIGNED BY
AUTHORISED PERSONNEL:
8.2 ARE ALL DOCUMENTS
PERIODICALLY REVISED:
8.3 ARE THE DOCUMENTS
UNAMBIGUOUS CLEAR EASY
FOR REPRODUCTION AND
EASY TO CHECK:
8.4 IS THERE ANY ALTERATIONS,
IN ENTRY MADE. IF YES, ARE
ALTERATIONS CLEAR,
LEGIBLE AND
INITIALLED(OVER WRITING IS
NOT PERMITTED):
8.5 ARE THE FOLLOWING
DOCUMENTS AVAILABLE WITH
NECESSARY DETAILS:
(L) TESTING PROCEDURES
FOR STARTING
MATERIALS,
INTERMEDIATE PRODUCTS
AND FINISHED
PRODUCTS,PACKING
MATERIALS:
(M)VALIDATION OF TESTING
PROCEDURE:
(N) MASTER FORMULA
CARD(COLLECT
SPECIMEN):
(O) PACKAGING INSTRUCTION
(COLLECT SPECIMEN):
© 2007 Center for Pharmaceutical Learning
(P) BATCH PROCESSING
CARDS INCLUDING
INPROCESS
CONTROLS.(COLLECT
SPECIMEN):
(Q) BATCH PACKAGING CARD
(COLLECT SPECIMEN):
(R) REFERENCE STANDARDS:
(S) DISPOSAL RECORD OF
OUTDATED PRIMARY AND
PRINTED PACKING
MATERIALS:
(T) RELEASE RECORDS:
(U) DISTRIBUTION
RECORDS.(WITH WHAT
LEVEL):
(V) COMPARE MASTER
FORMULA CARD WITH
ACTUAL PRACTICE:
8.6 ARE ALL RECORDS AND
ASSOCIATED SOPs RETAINED
UPTO ONE YEAR AFTER EXPIRY
OF FINISHED PRODUCT:
8.7 ARE STANDARD OPERATING
PROCEDURES FOR THE
FOLLOWING OPERATIONS
AVAILABLE:
(S) RECEIPT MATERIALS:
(T) ENVIRONMENTAL
MONITORING:
© 2007 Center for Pharmaceutical Learning
(U) INTERNAL LABELLING ,
QUARANTINE AND
STORAGE OF MATERIALS:
(V) EACH INSTRUMENT AND
EQUIPMENT IN THEIR
PREXIMITY:
(W)EQUIPMENT ASSEMBLY
AND VALIDATION:
(X) SAMPLING(RAW
MATERIALS AND FINISHED
PRODUCTS):
(Y) DISPENSING (RAW
MATERIALS AND PACKING
MATERIALS):
(Z) BATCH NUMBERING
SYSTEM:
(AA)RELEASE OR REJECTION:
(BB)LOG BOOK FOR EACH
EQUOPMENT AND
INSTRUMENT:
(CC)SANITATION AND
CLEANING OF PREMISES
AND EQUIPMENT:
(DD)SANITATION OF PIPES
CARRYING
DISTILLED/DEIONISED
WATER:
© 2007 Center for Pharmaceutical Learning
(EE)RECOVERY FROM
REJECTED PRODUCTS:
(FF)DISPOSAL/REUSE OF
RETURNED GOODS:
(GG)PEST CONTROL:
(HH)ANALYTICAL APPARATUS
AND CALIBRATION:
(II) COMPLAINTS,RECALLS
AND RETURNS:
(JJ) COMPARE SOPs WITH
ACTUAL PRACTICE:
11. PRODUCTION:
9.1 IS THERE ANY DEVIATION
FROM SOPs MANUFACTURING
PROCEDURES:
9.2 IS YIELD CHECKED AT EACH
STAGE:
9.3 IS MORE THAN ONE PRODUCT
PROCESSED IN THE SAME
ROOM:
9.4 ARE EQUIPMENTS AND ROOMS
LABELLED TO INDICATE THE
OPERATION IN PROGRESS:
9.5 IS ANY NON MEDICAL
PRODUCT PRODUCED. SPECIFY
THE DETAILS:
9.6 IS THERE PROVISION FOR
INPROCESS CONTROLS IN THE
PRODUCTION AREA(MUST NOT
EFFECT THE QUALITY OF THE
PRIODUCTS MANUFACTURED):
9.7 IS THERE PROVISION FOR
© 2007 Center for Pharmaceutical Learning
DUST COLLECTION WHERE
DRY MATERIALS ARE
HANDLED:
9.8 IS PERIODICAL MICROBIAL
MONITORING OF PRODUCTION
AREAS OF SUCEPTIBLE
PRODUCTS CONDUCTED:
9.9 WAS THE AREA BEING
CLEANED BEFORE STARTING
EVERY BATCH:
9.10 ARE PIPES CARRYING
DISTILLED/DEIONISED WATER
SANITIZED ACCORDING TO
PROCEDURE WHICH INDICATE
LIMITS FOR MICROBIAL
CONTAMINATION AND
MEASURES TO BE TAKEN:
9.11 WAS ANY BATCH
REPROCESSED FROM
REJECTED PRODUCTS:
9.12 WAS ANY BATCH RETURNED
HAS BEEN CONVERTED FOR
RESALE , RELABELLING OR
BULKING:
12. PACKAGING:
10.1 IS THERE ADEQUATE
SEPARATION OF PACKING
LINES TO PREVENT ANY MIX-
UP:
10.2 IS EACH PACKAGING LINE
IDENTIFIED WITH PRODUCT
NAME, BATCH NO. AND
PACKAGING SIZE:
10.3 IS ONLY ONE PRODUCT,
BATCH AND PACKAGING SIZE
ON A LINE AT ANY GIVEN
TIME:
10.4 IS LINE CLEARED BEFORE
EACH BATCH
OPERATION,CERTIFIED AND
RECORDED:
10.5 DOES PACKING QUICKLY
© 2007 Center for Pharmaceutical Learning
FOLLOWS THE FILLING AND
SEALING:
10.6 ARE ALL CODED PACKING
MATERIALS VERIFIED BEFORE
USE.
10.7 IS RECONCILATION OF
PACKING MATERIALS USED
VIS-À-VIS PRODUCT
RECORDED:
10.8 IS ON LINE COTROL
PROCEDURE DURING PACKING
AVAILABLE:
13. QUALITY CONTROL:
11.1 HOW FAR THE HEAD OF
QUALITY CONTROL AND
PRODUCTION ARE
INDEPENDENT OF EACH OTHER:
11.2 ARE ALL THE PROCEDURES OF
DOCUMEBNTED:
11.3 IS SAMPLING PROCEDURE
ADEQUATE:
11.4 DO THE LABEL ON SAMPLE
CONTAINER, SHOW BATCH NO. ,
NAME,CONTAINER NO., DATE
OF SAMPLING AND PERSON
WHO SAMPLED:
11.5 IS IDENTIFY TEST DONE ON
EACH CONTAINER OF STARTING
MATERIALS:
11.6 ARE ANALYTICAL RECORDS OF
EACH BATCH OF THE RAW
MATERIALS,INTERMEDIATES
AND FINISHED PRODUCTS
AVAILABLE WITH WORK
SHEETS:
11.7 ARE PRODUCTION RECORDS
REVIEWED:
11.8 ARE ALL RETENTION SAMPLES
KEPT FOR ONE YEAR AFTER
EXPIRY DATE AND OTHER
© 2007 Center for Pharmaceutical Learning
STARTING MATERIALS FOR A
MINIMUM OF TWO YEARS:
11.9 IS PROGRAMME FOR STABILITY
TESTING OF STARTING
MATERIALS AND FINISHED
PRODUCTS AVAILABLE:
11.10 IS STABILITY TESTING
CONDUCTED PRIOR TO
MARKETING AND AFTER
CHANGE OF PROCESS
EQUIPMENT,PACKING
MATERIALS:
11.11 IS QUALITY CONTROL LAB
SEPARATE FROM PRODUCTION
AREA:
11.12 ARE BIOLOGICAL AND
MICROBIOLOGICAL TESTING
AREAS SEPARATE FROM EACH
OTHER,AND DO THEY HAVE
SEPARATE AIR HANDLING
FACILITIES:
11.13 IS INSTRUMENT ROOM
SEPARATE:
11.14 IS DESIGN OF LAB SUITABLE
WITH ADEQUATE
SPACE,VENTILATION AND FOR
PREVENTION OF FUMES:
11.15 ARE RECORDS OF SERVICE AND
CALIBRATION OF INSTRUMENT
AVAILABLE:
11.16 ARE APPROPRIATE SAMPLING
EQUIPMENT AVAILABLE AND
STARTED SEPARATELY:
11.17 ARE INSTRUMENTS CHECKED
DAILY OR PRIOR TO USE:
11.18 ARE DATE OF CALIBRATION ,
SERVICE ,AND DATE WHEN
RECALIBRATION DUE
INDICATED:
11.19 ARE THE REAGENTS PREPARED
ACCORDING TO WRITTEN
PROCEDURES AND LABELLED
APPROPRIATELY:
© 2007 Center for Pharmaceutical Learning
11.20 ARE REFERENCE STANDARDS
AVAILABLE CORRESPOND TO
THE MATERIALS ANALYSED:
11.21 IS ADEQUATE STORAGE SPACE
(IF NECESSARY WITH COOLING)
AND RECORDS ARE AVAILABLE
FOR REFERENCE STANDARDS
AND REFERENCE SAMPLES.
CHECK THE MODE OF STORAGE
OF REFERENCE STANDARDS:
11.22 ARE WORKING STANDARDS
CHECKED AT REGULAR
INTERVALS:
11.23 ARE THE LABELS OF REF.
STANDARDS INDICATE NAME,
DATE OF MFG. DATE OF
EXPIRY,CONCENTRATION AND
DATE OF CLOSURE IS FIRST
OPENED AND STORAGE
CONDITIONS:
11.24 ARE THE LABEL OF REAGENTS
PREPARED SHOW
CONCENTRATION ,
STANDARDISATION FACTOR,
SELF- LIFE,STANDARDISATION
DATE ,STORAGE CONDITION
AND SIGNATURE OF THE
PERSON PREPARES THE
REAGENTS:
11.25 ARE POSITIVE AND NEGATIVE
CONTROLS USED TO TEST
SUITABILITY OF CULTURE
MEDIA:
11.26 ARE STABILITY STUDIES
CONDUCTED BEFORE
ASSIGNING SHELF LIFE AND IS
IT PERIODICALL REVIEWED,
AND GIVE DETAILS:
14. SELF INSPECTION:
© 2007 Center for Pharmaceutical Learning
GIVE DETAILS OF NAMES,
QUALIFICATION AND BACKGROUND
OF THE MEMBERS OF SELF
INSPECTION TEAM:
12.1 INTERVAL PERIOD BETWEEN
SELF INSPECTIONS:
12.2 DOES SELF INSPECTION REPORT
CONTAINS COMMENTS ON:
(P) PERSONNEL:
(Q) PREMISES:
(R) MAINTENANCE OF
BUILDING AND
EQUIPMENT:
(S) STORAGE:
(T) EQUIPMENT:
(U) PRODUCTION AND
INPROCESS CONTROL:
(V) QUALITY CONTROL:
(W)DOCUMENTATION:
(X) SANITATION AND
HYGIENE:
(Y) VALIDATION PROCEDURE
/ PROGRAMMES:
(Z) CALIBRATION OF
INSTRUMENTS:
© 2007 Center for Pharmaceutical Learning
(AA)RECALL PROCEDURES:
(BB)LABELS CONTROL:
(CC)COMPLAINTS:
(DD)CORRECTIVE ACTION
ON PREVIOUS REPORTS:
13. RECALL PROCEDURE :
EXPLAIN PROCEDURE ADOPTED FOR
RECALL OF PRODUCTS:
14. QUALITY AUDIT SYSTEM :
(BRIEF RESPONSIBILITIES)
© 2007 Center for Pharmaceutical Learning
REMARKS:

Gmp checklist

  • 1.
    © 2007 Centerfor Pharmaceutical Learning W.H.O. G.M.P. INSPECTION PERFORMA DATE OF INSPECTING FIRM’S REPRESENTATIVES INSPECTION OFFICERS: PRESENT DURING INSPECTION FIRM’S NAME: PHONE NO. : ADDRESS: LICENCE NO.: CATEGORIES OF DRUGS MANUFACTURED AND PRODUCTION CAPACITY: DETAILS OF EXPORT, IF UNDERTAKEN ALREADY: TECHNICAL PERSONNEL: MANUFACTURING: QUALITY CONTROL: PRODUCTS TO BE CERTIFIED: PRODUCTS LICENSED: WHETHER SITEMASTER FILE SUBMITTED IF YES, COMMENTS OF INSPECTING OFFICER ON SITE MASTER FILE.
  • 2.
    © 2007 Centerfor Pharmaceutical Learning Complaint Yes/No Remark if non complaint 1. PERSONNEL: 1.1 IS ORGANISATION CHART AVAILABLE: 1.2 ARE NO. OF PERSONNEL ADEQUATE: 1.3 NAME ,QUALIFICATION AND EXPERIENCE OF KEY PERSONNEL(CHECK WITH SMF): 1.4 IS QUALIFICATION AND EXPERIENCE OF PERSONNEL COMMENSURATE WITH JOB DESCRIPTION: 1.5 IS MANAGERIAL RESPONCIBILITIES OF EACH TECHNICAL PERSONNEL SPECIFIED IN WRITTING WITH JOB DESCRIPTION: 1.6 CHECK WHETHER THERE ARE GAPS OR UNEXPLAINED OVERLAP OF RESPONSIBILITIES OF THE CONCERNED PERSONNEL: 2. TRAINING OF PERSONNEL: 2.1 IS WRITTEN PROGRAMME FOR TRAINING AVAILABLE: 2.2 ARE ALL PERSONNEL TRAINED INITIALLY: 2.3 ARE PERIODICAL ASSESMENT RECORDS AVAILABLE 2.4 IS SPECIAL PROGRAMME AVAILABLE FOR PERSONNEL WORKING IN CLEAN AREAS AND AREAS WHERE HIGHLY ACTIVE AND TOXIC MATERIAL & HANDLED: 2.5 IS SOPs FOR TRAINING OF PERSONNEL AVAILABLE: 3. PERSONNEL HYGIENE OF PERSONNEL: 3.1 ARE ALL PERSONNEL MEDICALLY EXAMINED PRIOR TO = AND DURING EMPLOYMENT: 3.2 ARE THEY RESTRICTED , IF MEDICAL REASONS DICTATE: 3.3 IS SOPs FOR CLOTHING AND HYGIENE AVAILABLE:
  • 3.
    © 2007 Centerfor Pharmaceutical Learning 3.4 ARE CLEAN UNIFORMS AND HAIR COVERING CAPS USED: 3.5 CHECK NO. OF UNIFORMS PROVIDED. ARE THEY ADEQUATE: 3.6 WHAT PROTECTIVE CLOTHING ARE PROVIDED FOR VISITORS / OUTSIDE PERSONNEL ENTERING IN PRODUCTION AREAS. ARE THEY ADEQUATE: 4. PREMISES : 4.1 BRIEF DESCRIPTION OF BUILDING 4.2 IS DESIGNS AND CONSTRUCTED: 4.3 IS THE PREMISES COMPLY WITH SMF AND SITUATED IN AN ENVIRONMENT WHICH CAUSED MINIMUM RISK OF CONTAMINATION TO MATERIALS OR PRODUCTS: 4.4 IS AREA PROVIDED COMMENSURATE WITH PRODUCTION: 4.5 ARE NON MEDICAL PRODUCTS MANUFACTURED IN THE PREMISES. IF YES, GIVE DETAILS: 4.6 ARE SOPs AVAILABLE FOR MAINTENANCE, CLEANING AND SANITATION OF BUILDINGS, PREMISES AND SURROUNDING 4.7 CHECK WHETHER THE AREA IS CLEANED AND VALIDATED BEFORE STARTING STORING /PROCESING /PACKING OPERATIONS: 4.8 IS ELECTRICAL SUPPLY, LIGHTING,TEMPERATURE,HUMIDITY,AND VENTILATION APPROPRIATE: 4.9 ARE ARRANGEMENT MADE FOR CONTROL OF ENTRY OF RODENTS& BIRD 4.10 ARE FOLLOWING AREAS PROVIDED: (A) SEPARATE REST ROOMS AND REFRESHMENT ROOMS: (B) SEPARATE CHANGING ROOMS AND TOILETS FOR MALE AND FEMALE WORKERS: (C) WORKSHOP IN A SEPARATE PLACE: (D) ANIMAL HOUSES WITH SEPARATE ENTRY AND AIR HANDLING UNIT: 5. STORAGE AREAS: 5.1 IS AREA SUFFICIENT FOR ORDERLY STORAGE
  • 4.
    © 2007 Centerfor Pharmaceutical Learning OF MATERIALS: 5.2 INDICATE AREAS FOR EACH CATEGORY AND WHETHER BARRIERS ARE PROVIDED IF NOT, EXPLAIN MODE OF SEGREGATION: RAW MATERIALS: QUARANTINE: APPROVED: REJECTED: PACKING MATERIALS: IS ACCESS TO QUARANTINE AREA RESTRICTED: 5.4 ARE REJECTED GOODS MARKED AND STORED SEPARATELY IN A SECURED AREA: 5.5 ARE RECORDS FOR ACTION TAKEN ON REJECTED GOODS AVAILABLE: 5.6 ARE FACILITIES AVAILABLE FOR STORAGE IN CONTROLLED TEMPERATURE/ HUMIDITY: 5.7 IS RECORD OF TEMPERATURE AND HUMIDITY MAINTAINED: 5.8 ARE RECEIVING BAYS COVERED 5.9 ARE INCOMING MATERIALS CLEANED BEFORE ENTRY TO STORAGE AREA: 5.10 IS SEPARATE SAMPLING AREA PROVIDED.IF , NOT HOW CONTAMINATION AND CROSS CONTAMINATION IS PREVENTED: 5.11 ARE SENSITIVE MATERIALS/ HORMONES,BLACTUM, ANTIBIOTICS, NARCOTICS,INFLAMMABLES, EXPLOSIVES STORED IN SECURED AREA: 5.12 ARE PRINTED/CODED PACKING MATERIALS AND CUT LABELS STORED IN SECURED AREA WITH RESTRICTED ENTRY,AND WHETHER PACKING MATERIALS LINE LABELS,CARTONS.LEAFLETS ARE IN PIGEON HOLE, ALMIRAH: 5.13 IS DISPENSING AREA PROVIDED WITH DUST
  • 5.
    © 2007 Centerfor Pharmaceutical Learning CONTROL PROVISION: 5.14 DESCRIBE THE PRIMARY PACKING MATERIALS STORAGE AREA: 6. PRODUCTION AREA: 6.1 ARE PRODUCTION AREAS FOR THE FOLLOWINGS SEPARATED AND SELF CONTAIN. DESCRIBE THE NATURE OF SEPARATION: (A) BETA- LACTUM ANTIBIOTICS: (B) HORMONES/CORTICOSTEROIDS (C) OTHER DRUGS. 6.2 WHETHER THE ACCESS TO PRODUCTION AREA RESTRICTED TO AUTHORISED PERSONNEL: 6.3 ARE WALLS, FLOORS AND CEILING SMOOTH AND FREE FROM CRACKS: 6.4 IS THE PRODUCTION AREA WELL-LIT: 6.5 HOW CROSS CONTAMINATION OF STARTING MATERIAL OR OF A PRODUCT BY ANOTHER MATERIAL OR PRODUCT IS PREVENTED: 6.6 IS THE LAY OUT OF MANUFACTURING DIVISION OF EACH CATEGORY OF DOSAGE FORM IN LOGICAL SEQUENCE. IF NOT, GIVE DETAILS WITH REFERENCE TO FLOOR PLAN: 6.7 IS WORKING SPACE ADEQUATE AND ATLEAST ONE METER PROVIDED AROUND FOR EACH EQUIPMENT: 6.8 ARE SERVICE LINES, LIGHT FITTINGS CONCEALED AND FLUSHED TO THE SURFACE OR MADE ACCESSIBLE FROM OUTSIDE. LOOK FOR PROTRUDING SURFACE AND SPECIFY: 6.9 ARE DRAINE PROVIDED WITH TRAPS TO AVOID BACK FLOW 6.10 ARE DRAINS CLEANED AND DISINFECTED PERIODICALLY. CHECK RECORDS: 6.11 IS PRODUCTION AREA PROVIDED WITH PROPER VENTILATION WITH AIRCONTROL FACILITIES (FILTRATION, TEMPERATURE AND HUMIDITY).ARE RECORDS MAINTAINED
  • 6.
    © 2007 Centerfor Pharmaceutical Learning THEREOF. 6.12 ARE LOCKERS PROVIDED FOR STORAGE OF TOOLS AND PARTS: 6.13 ARE PACKAGING AND VISUAL INSPECTION AREAS DESIGNED TO FACILITATE SEGREGATION FOR EACH WORK LINE: 6.14 ARE EQUIPMENTS: (A) LOCATED IN LOGICAL SEQUENCE (GIVE BRIEF DESCRIPTION): (B) DESIGNED, CONSTRUCTED TO SUIT THE PURPOSE: (C) PERMIT EFFECTIVE CLEANING: (D) CLEANED BETWEEN BATCH OPERATION AND RECORDED.CHECK RECORDS: (E) CALLED TO INDICATE THEIR STATUS: 6.15 ARE SERVICE LINES PAINTED TO INDICATE THE CONTENTS AND FLOW. RECORDS THE ORDER SCHEME: 6.16 ARE BALANCES AND MEASURING EQUIPMENTS CALIBRATED PERIODICALLY.CHECK RECORDS AND PERIODICITY: 6.17 ARE WEIGHING EQUIPMENTS AND MEASURING EQUIPMENTS OF APPROPRIATE RANGE AND PRECISION AVAILABLE. CHECK CAPACITY OF THE EQUIPMENT VIS-À-VIS BATCH SIZES OF PRODUCTION: 6.18 CHECK THE TYPE OF WASHING AND CLEANING EQUIPMENTS IN PRODUCTION AREA.(PARTICLE GENERATING EQUIPMENTS SHOULD NOT BE USED): 6.19 HOW DEFECTIVE EQUIPMENTS ARE SEGREGATED: 7. MATERIALS: 7.1 IS SEGREGATION IS LOTWISE AND STOCK ROTATION BY FIFO ADOPTED: 7.2 DOES PURCHASE DEPARTMENT STAFF KNOWLEDGEABLE ABOUT THE PRODUCTS AND MATERIALS: 7.3 HOW SUPPLIERS ARE SELECTED: 7.4 ARE SUPPLIERS EVALUATED AND APPROVED AND THEIR NAME INCLUDED IN SPECIFICATION:
  • 7.
    © 2007 Centerfor Pharmaceutical Learning 7.5 ARE PURCHASES MADE DIRECTLY FROM PRODUCERS: 7.6 ARE MATERIALS CHECKED FOR INTEGRITY AND CONFORMITY WITH ORDER ON RECEIPT: 7.7 IS DAMAGE RECORDED AND REPORTED TO QUALITY CONTROL: 7.8 DO THE LABELS SHOW B.NO, NAME, C.R.NO. , STATUS,EXPIRY DATE , RETEST DATE ETC.(COLLECT) SAMPLE OF INHOUSE LABELS): 7.9 IS COLOUR CODING SYSTEM USED TO INDICATE STATUS: 7.10 ARE SAMPLE CONTAINERS IDENTIFIED AND RELEASED: 7.11 ARE WRITTEN PRODUCERS FOR SAMPLING AND DISPENSING AVAILABLE. COMPARE SOPs WITH ACTUAL PRACTICE: 7.12 IS SAMPLING AND DISPENSING DONE BY DESIGNATED PERSONS: 7.13 IS EACH DISPENSING CHECKED AND RECORDED. 7.14 IS ADEQUATE STORAGE AREA FOR FINISHED GOODS PROVIDED: 7.15 IS ADEQUATE AREA FOR RECALLED/RETURNED PRODUCTS PROVIDED: 7.16 ARE PACKING MATERIALS CHECKED ON DELIVERY AND ASSIGNED A SPECIFIC REFERENCE NUMBER: 7.17 HOW THE WASTE MATERIALS FROM STORE,PRODUCTION, QUALITYCONTROL DISPOSED OFF: 7.18 IS THERE ACCUMULATION OF WASTE MATERIAL AT ANY PART OF THE STORAGE/ PRODUCTION/Q.C.AREA: 8. DOCUMENTATION: 8.1 ARE ALL DOCUMENTS PREPARED AND REVIEWED BY COMPETENT PERSONNEL APPROVED AND SIGNED BY AUTHORISED PERSONNEL: 8.2 ARE ALL DOCUMENTS PERIODICALLY REVISED: 8.3 ARE THE DOCUMENTS UNAMBIGUOUS CLEAR EASY FOR REPRODUCTION AND EASY TO CHECK:
  • 8.
    © 2007 Centerfor Pharmaceutical Learning 8.4 IS THERE ANY ALTERATIONS, IN ENTRY MADE. IF YES, ARE ALTERATIONS CLEAR, LEGIBLE AND INITIALLED(OVER WRITING IS NOT PERMITTED): 8.5 ARE THE FOLLOWING DOCUMENTS AVAILABLE WITH NECESSARY DETAILS: (A) TESTING PROCEDURES FOR STARTING MATERIALS, INTERMEDIATE PRODUCTS AND FINISHED PRODUCTS,PACKING MATERIALS: (B) VALIDATION OF TESTING PROCEDURE: (C) MASTER FORMULA CARD(COLLECT SPECIMEN): (D) PACKAGING INSTRUCTION (COLLECT SPECIMEN): (E) BATCH PROCESSING CARDS INCLUDING INPROCESS CONTROLS.(COLLECT SPECIMEN): (F) BATCH PACKAGING CARD (COLLECT SPECIMEN): (G) REFERENCE STANDARDS: (H) DISPOSAL RECORD OF OUTDATED PRIMARY AND PRINTED PACKING MATERIALS: (I) RELEASE RECORDS: (J) DISTRIBUTION RECORDS.(WITH WHAT LEVEL): (K) COMPARE MASTER FORMULA CARD WITH
  • 9.
    © 2007 Centerfor Pharmaceutical Learning ACTUAL PRACTICE: 8.6 ARE ALL RECORDS AND ASSOCIATED SOPs RETAINED UPTO ONE YEAR AFTER EXPIRY OF FINISHED PRODUCT: 8.7 ARE STANDARD OPERATING PROCEDURES FOR THE FOLLOWING OPERATIONS AVAILABLE: (A) RECEIPT MATERIALS: (B) ENVIRONMENTAL MONITORING: (C) INTERNAL LABELLING , QUARANTINE AND STORAGE OF MATERIALS: (D) EACH INSTRUMENT AND EQUIPMENT IN THEIR PREXIMITY: (E) EQUIPMENT ASSEMBLY AND VALIDATION: (F) SAMPLING(RAW MATERIALS AND FINISHED PRODUCTS): (G) DISPENSING (RAW MATERIALS AND PACKING MATERIALS): (H) BATCH NUMBERING SYSTEM: (I) RELEASE OR REJECTION: (J) LOG BOOK FOR EACH EQUOPMENT AND INSTRUMENT: (K) SANITATION AND CLEANING OF PREMISES AND EQUIPMENT: (L) SANITATION OF PIPES CARRYING DISTILLED/DEIONISED WATER:
  • 10.
    © 2007 Centerfor Pharmaceutical Learning (M)RECOVERY FROM REJECTED PRODUCTS: (N) DISPOSAL/REUSE OF RETURNED GOODS: (O) PEST CONTROL: (P) ANALYTICAL APPARATUS AND CALIBRATION: (Q) COMPLAINTS,RECALLS AND RETURNS: (R) COMPARE SOPs WITH ACTUAL PRACTICE: 9. PRODUCTION: 9.1 IS THERE ANY DEVIATION FROM SOPs MANUFACTURING PROCEDURES: 9.2 IS YIELD CHECKED AT EACH STAGE: 9.3 IS MORE THAN ONE PRODUCT PROCESSED IN THE SAME ROOM: 9.4 ARE EQUIPMENTS AND ROOMS LABELLED TO INDICATE THE OPERATION IN PROGRESS: 9.5 IS ANY NON MEDICAL PRODUCT PRODUCED. SPECIFY THE DETAILS: 9.6 IS THERE PROVISION FOR INPROCESS CONTROLS IN THE PRODUCTION AREA(MUST NOT EFFECT THE QUALITY OF THE PRIODUCTS MANUFACTURED): 9.7 IS THERE PROVISION FOR DUST COLLECTION WHERE DRY MATERIALS ARE HANDLED: 9.8 IS PERIODICAL MICROBIAL MONITORING OF PRODUCTION AREAS OF SUCEPTIBLE PRODUCTS CONDUCTED: 9.9 WAS THE AREA BEING CLEANED BEFORE STARTING EVERY BATCH: 9.10 ARE PIPES CARRYING DISTILLED/DEIONISED WATER SANITIZED ACCORDING TO PROCEDURE WHICH INDICATE LIMITS FOR MICROBIAL CONTAMINATION AND MEASURES TO BE TAKEN: 9.11 WAS ANY BATCH REPROCESSED FROM
  • 11.
    © 2007 Centerfor Pharmaceutical Learning REJECTED PRODUCTS: 9.12 WAS ANY BATCH RETURNED HAS BEEN CONVERTED FOR RESALE , RELABELLING OR BULKING: 10. PACKAGING: 10.1 IS THERE ADEQUATE SEPARATION OF PACKING LINES TO PREVENT ANY MIX-UP: 10.2 IS EACH PACKAGING LINE IDENTIFIED WITH PRODUCT NAME, BATCH NO. AND PACKAGING SIZE: 10.3 IS ONLY ONE PRODUCT, BATCH AND PACKAGING SIZE ON A LINE AT ANY GIVEN TIME: 10.4 IS LINE CLEARED BEFORE EACH BATCH OPERATION,CERTIFIED AND RECORDED: 10.5 DOES PACKING QUICKLY FOLLOWS THE FILLING AND SEALING: 10.6 ARE ALL CODED PACKING MATERIALS VERIFIED BEFORE USE. 10.7 IS RECONCILATION OF PACKING MATERIALS USED VIS-À-VIS PRODUCT RECORDED: 10.8 IS ON LINE COTROL PROCEDURE DURING PACKING AVAILABLE: 11. QUALITY CONTROL: 11.1 HOW FAR THE HEAD OF QUALITY CONTROL AND PRODUCTION ARE INDEPENDENT OF EACH OTHER: 11.2 ARE ALL THE PROCEDURES OF DOCUMEBNTED: 11.3 IS SAMPLING PROCEDURE ADEQUATE: 11.4 DO THE LABEL ON SAMPLE CONTAINER, SHOW BATCH NO. , NAME,CONTAINER NO., DATE OF SAMPLING AND PERSON WHO SAMPLED: 11.5 IS IDENTIFY TEST DONE ON EACH CONTAINER OF STARTING MATERIALS: 11.6 ARE ANALYTICAL RECORDS OF EACH BATCH OF THE RAW MATERIALS,INTERMEDIATES AND FINISHED PRODUCTS AVAILABLE WITH WORK SHEETS: 11.7 ARE PRODUCTION RECORDS REVIEWED: 11.8 ARE ALL RETENTION SAMPLES KEPT FOR ONE YEAR AFTER EXPIRY DATE AND OTHER
  • 12.
    © 2007 Centerfor Pharmaceutical Learning STARTING MATERIALS FOR A MINIMUM OF TWO YEARS: 11.9 IS PROGRAMME FOR STABILITY TESTING OF STARTING MATERIALS AND FINISHED PRODUCTS AVAILABLE: 11.10 IS STABILITY TESTING CONDUCTED PRIOR TO MARKETING AND AFTER CHANGE OF PROCESS EQUIPMENT,PACKING MATERIALS: 11.11 IS QUALITY CONTROL LAB SEPARATE FROM PRODUCTION AREA: 11.12 ARE BIOLOGICAL AND MICROBIOLOGICAL TESTING AREAS SEPARATE FROM EACH OTHER,AND DO THEY HAVE SEPARATE AIR HANDLING FACILITIES: 11.13 IS INSTRUMENT ROOM SEPARATE: 11.14 IS DESIGN OF LAB SUITABLE WITH ADEQUATE SPACE,VENTILATION AND FOR PREVENTION OF FUMES: 11.15 ARE RECORDS OF SERVICE AND CALIBRATION OF INSTRUMENT AVAILABLE: 11.16 ARE APPROPRIATE SAMPLING EQUIPMENT AVAILABLE AND STARTED SEPARATELY: 11.17 ARE INSTRUMENTS CHECKED DAILY OR PRIOR TO USE: 11.18 ARE DATE OF CALIBRATION , SERVICE ,AND DATE WHEN RECALIBRATION DUE INDICATED: 11.19 ARE THE REAGENTS PREPARED ACCORDING TO WRITTEN PROCEDURES AND LABELLED APPROPRIATELY: 11.20 ARE REFERENCE STANDARDS AVAILABLE CORRESPOND TO THE MATERIALS ANALYSED: 11.21 IS ADEQUATE STORAGE SPACE (IF NECESSARY WITH COOLING) AND RECORDS ARE AVAILABLE FOR REFERENCE STANDARDS AND REFERENCE SAMPLES. CHECK THE MODE OF STORAGE OF REFERENCE STANDARDS: 11.22 ARE WORKING STANDARDS CHECKED AT REGULAR INTERVALS: 11.23 ARE THE LABELS OF REF. STANDARDS INDICATE NAME, DATE OF MFG. DATE OF EXPIRY,CONCENTRATION AND DATE OF CLOSURE IS FIRST OPENED AND STORAGE CONDITIONS:
  • 13.
    © 2007 Centerfor Pharmaceutical Learning 11.24 ARE THE LABEL OF REAGENTS PREPARED SHOW CONCENTRATION , STANDARDISATION FACTOR, SELF- LIFE,STANDARDISATION DATE ,STORAGE CONDITION AND SIGNATURE OF THE PERSON PREPARES THE REAGENTS: 11.25 ARE POSITIVE AND NEGATIVE CONTROLS USED TO TEST SUITABILITY OF CULTURE MEDIA: 11.26 ARE STABILITY STUDIES CONDUCTED BEFORE ASSIGNING SHELF LIFE AND IS IT PERIODICALL REVIEWED, AND GIVE DETAILS: 12. SELF INSPECTION: GIVE DETAILS OF NAMES, QUALIFICATION AND BACKGROUND OF THE MEMBERS OF SELF INSPECTION TEAM: 12.1 INTERVAL PERIOD BETWEEN SELF INSPECTIONS: 12.2 DOES SELF INSPECTION REPORT CONTAINS COMMENTS ON: (A) PERSONNEL: (B) PREMISES: (C) MAINTENANCE OF BUILDING AND EQUIPMENT: (D) STORAGE: (E) EQUIPMENT: (F) PRODUCTION AND INPROCESS CONTROL: (G)QUALITY CONTROL: (H) DOCUMENTATION:
  • 14.
    © 2007 Centerfor Pharmaceutical Learning (I) SANITATION AND HYGIENE: (J) VALIDATION PROCEDURE / PROGRAMMES: (K) CALIBRATION OF INSTRUMENTS: (L) RECALL PROCEDURES: (M)LABELS CONTROL: (N) COMPLAINTS: (O)CORRECTIVE ACTION ON PREVIOUS REPORTS: 13 RECALL PROCEDURE : EXPLAIN PROCEDURE ADOPTED FOR RECALL OF PRODUCTS: 14 QUALITY AUDIT SYSTEM : (BRIEF RESPONSIBILITIES REMARKS: 1.1 IS ORGANISATION CHART AVAILABLE: 1.2 ARE NO. OF PERSONNEL ADEQUATE: 1.3 NAME ,QUALIFICATION AND EXPERIENCE OF KEY PERSONNEL(CHECK WITH SMF): 1.4 IS QUALIFICATION AND EXPERIENCE OF PERSONNEL COMMENSURATE WITH JOB DESCRIPTION: 1.5 IS MANAGERIAL RESPONCIBILITIES OF EACH
  • 15.
    © 2007 Centerfor Pharmaceutical Learning TECHNICAL PERSONNEL SPECIFIED IN WRITTING WITH JOB DESCRIPTION: 1.6 CHECK WHETHER THERE ARE GAPS OR UNEXPLAINED OVERLAP OF RESPONSIBILITIES OF THE CONCERNED PERSONNEL: 2. TRAINING OF PERSONNEL: 2.1 IS WRITTEN PROGRAMME FOR TRAINING AVAILABLE: 2.2 ARE ALL PERSONNEL TRAINED INITIALLY: 2.3 ARE PERIODICAL ASSESMENT RECORDS AVAILABLE 2.4 IS SPECIAL PROGRAMME AVAILABLE FOR PERSONNEL WORKING IN CLEAN AREAS AND AREAS WHERE HIGHLY ACTIVE AND TOXIC MATERIAL & HANDLED: 2.5 IS SOPs FOR TRAINING OF PERSONNEL AVAILABLE: 3. PERSONNEL HYGIENE OF PERSONNEL: 3.1 ARE ALL PERSONNEL MEDICALLY EXAMINED PRIOR TO = AND DURING EMPLOYMENT: 3.2 ARE THEY RESTRICTED , IF MEDICAL REASONS DICTATE: 3.3 IS SOPs FOR CLOTHING AND HYGIENE AVAILABLE: 3.4 ARE CLEAN UNIFORMS AND HAIR COVERING CAPS USED: 3.5 CHECK NO. OF UNIFORMS
  • 16.
    © 2007 Centerfor Pharmaceutical Learning PROVIDED. ARE THEY ADEQUATE: 3.6 WHAT PROTECTIVE CLOTHING ARE PROVIDED FOR VISITORS / OUTSIDE PERSONNEL ENTERING IN PRODUCTION AREAS. ARE THEY ADEQUATE: 6. PREMISES : 4.1 BRIEF DESCRIPTION OF BUILDING 4.2 IS DESIGNS AND CONSTRUCTED: 4.3 IS THE PREMISES COMPLY WITH SMF AND SITUATED IN AN ENVIRONMENT WHICH CAUSED MINIMUM RISK OF CONTAMINATION TO MATERIALS OR PRODUCTS: 4.4 IS AREA PROVIDED COMMENSURATE WITH PRODUCTION: 4.5 ARE NON MEDICAL PRODUCTS MANUFACTURED IN THE PREMISES. IF YES, GIVE DETAILS: 4.6 ARE SOPs AVAILABLE FOR MAINTENANCE, CLEANING AND SANITATION OF BUILDINGS, PREMISES AND SURROUNDING 4.7 CHECK WHETHER THE AREA IS CLEANED AND VALIDATED BEFORE STARTING STORING /PROCESING /PACKING OPERATIONS: 4.8 IS ELECTRICAL SUPPLY, LIGHTING,TEMPERATURE,HUMIDITY,AND VENTILATION APPROPRIATE: 4.9 ARE ARRANGEMENT MADE FOR CONTROL OF ENTRY OF RODENTS& BIRD 4.10 ARE FOLLOWING AREAS PROVIDED: (A) SEPARATE REST ROOMS AND REFRESHMENT ROOMS: (B) SEPARATE CHANGING ROOMS AND TOILETS FOR MALE AND
  • 17.
    © 2007 Centerfor Pharmaceutical Learning FEMALE WORKERS: (C) WORKSHOP IN A SEPARATE PLACE: (D) ANIMAL HOUSES WITH SEPARATE ENTRY AND AIR HANDLING UNIT: 7. STORAGE AREAS: 5.1 IS AREA SUFFICIENT FOR ORDERLY STORAGE OF MATERIALS: 5.2 INDICATE AREAS FOR EACH CATEGORY AND WHETHER BARRIERS ARE PROVIDED IF NOT, EXPLAIN MODE OF SEGREGATION: RAW MATERIALS: QUARANTINE: APPROVED: REJECTED: PACKING MATERIALS: IS ACCESS TO QUARANTINE AREA RESTRICTED: 5.4 ARE REJECTED GOODS MARKED AND STORED SEPARATELY IN A SECURED AREA: 5.5 ARE RECORDS FOR ACTION TAKEN ON REJECTED GOODS AVAILABLE: 5.6 ARE FACILITIES AVAILABLE FOR STORAGE IN
  • 18.
    © 2007 Centerfor Pharmaceutical Learning CONTROLLED TEMPERATURE/ HUMIDITY: 5.7 IS RECORD OF TEMPERATURE AND HUMIDITY MAINTAINED: 5.8 ARE RECEIVING BAYS COVERED 5.9 ARE INCOMING MATERIALS CLEANED BEFORE ENTRY TO STORAGE AREA: 5.10 IS SEPARATE SAMPLING AREA PROVIDED.IF , NOT HOW CONTAMINATION AND CROSS CONTAMINATION IS PREVENTED: 5.11 ARE SENSITIVE MATERIALS/ HORMONES,BLACTUM, ANTIBIOTICS, NARCOTICS,INFLAMMABLES, EXPLOSIVES STORED IN SECURED AREA: 5.12 ARE PRINTED/CODED PACKING MATERIALS AND CUT LABELS STORED IN SECURED AREA WITH RESTRICTED ENTRY,AND WHETHER PACKING MATERIALS LINE LABELS,CARTONS.LEAFLETS ARE IN PIGEON HOLE, ALMIRAH: 5.13 IS DISPENSING AREA PROVIDED WITH DUST CONTROL PROVISION: 5.14 DESCRIBE THE PRIMARY PACKING MATERIALS STORAGE AREA: 7. PRODUCTION AREA:
  • 19.
    © 2007 Centerfor Pharmaceutical Learning 6.1 ARE PRODUCTION AREAS FOR THE FOLLOWINGS SEPARATED AND SELF CONTAIN. DESCRIBE THE NATURE OF SEPARATION: (D) BETA- LACTUM ANTIBIOTICS: (E) HORMONES/CORTICOSTEROIDS (F) OTHER DRUGS. 6.2 WHETHER THE ACCESS TO PRODUCTION AREA RESTRICTED TO AUTHORISED PERSONNEL: 6.3 ARE WALLS, FLOORS AND CEILING SMOOTH AND FREE FROM CRACKS: 6.4 IS THE PRODUCTION AREA WELL-LIT: 6.5 HOW CROSS CONTAMINATION OF STARTING MATERIAL OR OF A PRODUCT BY ANOTHER MATERIAL OR PRODUCT IS PREVENTED: 6.6 IS THE LAY OUT OF MANUFACTURING DIVISION OF EACH CATEGORY OF DOSAGE FORM IN LOGICAL SEQUENCE. IF NOT, GIVE DETAILS WITH REFERENCE TO FLOOR PLAN: 6.7 IS WORKING SPACE ADEQUATE AND ATLEAST ONE METER PROVIDED AROUND FOR EACH EQUIPMENT: 6.8 ARE SERVICE LINES, LIGHT FITTINGS CONCEALED AND FLUSHED TO THE SURFACE OR MADE ACCESSIBLE FROM OUTSIDE. LOOK FOR PROTRUDING SURFACE AND SPECIFY: 6.9 ARE DRAINE PROVIDED WITH
  • 20.
    © 2007 Centerfor Pharmaceutical Learning TRAPS TO AVOID BACK FLOW 6.10 ARE DRAINS CLEANED AND DISINFECTED PERIODICALLY. CHECK RECORDS: 6.11 IS PRODUCTION AREA PROVIDED WITH PROPER VENTILATION WITH AIRCONTROL FACILITIES (FILTRATION, TEMPERATURE AND HUMIDITY).ARE RECORDS MAINTAINED THEREOF. 6.12 ARE LOCKERS PROVIDED FOR STORAGE OF TOOLS AND PARTS: 6.13 ARE PACKAGING AND VISUAL INSPECTION AREAS DESIGNED TO FACILITATE SEGREGATION FOR EACH WORK LINE: 6.14 ARE EQUIPMENTS: (F) LOCATED IN LOGICAL SEQUENCE (GIVE BRIEF DESCRIPTION): (G) DESIGNED, CONSTRUCTED TO SUIT THE PURPOSE: (H) PERMIT EFFECTIVE CLEANING: (I) CLEANED BETWEEN BATCH OPERATION AND RECORDED.CHECK RECORDS: (J) CALLED TO INDICATE THEIR STATUS: 6.15 ARE SERVICE LINES PAINTED TO INDICATE THE CONTENTS AND FLOW. RECORDS THE ORDER SCHEME: 6.16 ARE BALANCES AND
  • 21.
    © 2007 Centerfor Pharmaceutical Learning MEASURING EQUIPMENTS CALIBRATED PERIODICALLY.CHECK RECORDS AND PERIODICITY: 6.17 ARE WEIGHING EQUIPMENTS AND MEASURING EQUIPMENTS OF APPROPRIATE RANGE AND PRECISION AVAILABLE. CHECK CAPACITY OF THE EQUIPMENT VIS-À-VIS BATCH SIZES OF PRODUCTION: 6.18 CHECK THE TYPE OF WASHING AND CLEANING EQUIPMENTS IN PRODUCTION AREA.(PARTICLE GENERATING EQUIPMENTS SHOULD NOT BE USED): 6.19 HOW DEFECTIVE EQUIPMENTS ARE SEGREGATED: 8. MATERIALS: 7.1 IS SEGREGATION IS LOTWISE AND STOCK ROTATION BY FIFO ADOPTED: 7.2 DOES PURCHASE DEPARTMENT STAFF KNOWLEDGEABLE ABOUT THE PRODUCTS AND MATERIALS: 7.3 HOW SUPPLIERS ARE SELECTED: 7.4 ARE SUPPLIERS EVALUATED AND APPROVED AND THEIR NAME INCLUDED IN SPECIFICATION: 7.5 ARE PURCHASES MADE DIRECTLY FROM PRODUCERS: 7.6 ARE MATERIALS CHECKED FOR INTEGRITY AND CONFORMITY WITH ORDER ON RECEIPT:
  • 22.
    © 2007 Centerfor Pharmaceutical Learning 7.7 IS DAMAGE RECORDED AND REPORTED TO QUALITY CONTROL: 7.8 DO THE LABELS SHOW B.NO, NAME, C.R.NO. , STATUS,EXPIRY DATE , RETEST DATE ETC.(COLLECT) SAMPLE OF INHOUSE LABELS): 7.9 IS COLOUR CODING SYSTEM USED TO INDICATE STATUS: 7.10 ARE SAMPLE CONTAINERS IDENTIFIED AND RELEASED: 7.11 ARE WRITTEN PRODUCERS FOR SAMPLING AND DISPENSING AVAILABLE. COMPARE SOPs WITH ACTUAL PRACTICE: 7.12 IS SAMPLING AND DISPENSING DONE BY DESIGNATED PERSONS: 7.13 IS EACH DISPENSING CHECKED AND RECORDED. 7.14 IS ADEQUATE STORAGE AREA FOR FINISHED GOODS PROVIDED: 7.15 IS ADEQUATE AREA FOR RECALLED/RETURNED PRODUCTS PROVIDED: 7.16 ARE PACKING MATERIALS CHECKED ON DELIVERY AND ASSIGNED A SPECIFIC REFERENCE NUMBER: 7.17 HOW THE WASTE MATERIALS FROM STORE,PRODUCTION, QUALITYCONTROL DISPOSED OFF: 7.18 IS THERE ACCUMULATION OF WASTE MATERIAL AT ANY PART OF THE STORAGE/ PRODUCTION/Q.C.AREA:
  • 23.
    © 2007 Centerfor Pharmaceutical Learning 9. DOCUMENTATION: 8.1 ARE ALL DOCUMENTS PREPARED AND REVIEWED BY COMPETENT PERSONNEL APPROVED AND SIGNED BY AUTHORISED PERSONNEL: 8.2 ARE ALL DOCUMENTS PERIODICALLY REVISED: 8.3 ARE THE DOCUMENTS UNAMBIGUOUS CLEAR EASY FOR REPRODUCTION AND EASY TO CHECK: 8.4 IS THERE ANY ALTERATIONS, IN ENTRY MADE. IF YES, ARE ALTERATIONS CLEAR, LEGIBLE AND INITIALLED(OVER WRITING IS NOT PERMITTED): 8.5 ARE THE FOLLOWING DOCUMENTS AVAILABLE WITH NECESSARY DETAILS: (L) TESTING PROCEDURES FOR STARTING MATERIALS, INTERMEDIATE PRODUCTS AND FINISHED PRODUCTS,PACKING MATERIALS: (M)VALIDATION OF TESTING PROCEDURE: (N) MASTER FORMULA CARD(COLLECT SPECIMEN): (O) PACKAGING INSTRUCTION (COLLECT SPECIMEN):
  • 24.
    © 2007 Centerfor Pharmaceutical Learning (P) BATCH PROCESSING CARDS INCLUDING INPROCESS CONTROLS.(COLLECT SPECIMEN): (Q) BATCH PACKAGING CARD (COLLECT SPECIMEN): (R) REFERENCE STANDARDS: (S) DISPOSAL RECORD OF OUTDATED PRIMARY AND PRINTED PACKING MATERIALS: (T) RELEASE RECORDS: (U) DISTRIBUTION RECORDS.(WITH WHAT LEVEL): (V) COMPARE MASTER FORMULA CARD WITH ACTUAL PRACTICE: 8.6 ARE ALL RECORDS AND ASSOCIATED SOPs RETAINED UPTO ONE YEAR AFTER EXPIRY OF FINISHED PRODUCT: 8.7 ARE STANDARD OPERATING PROCEDURES FOR THE FOLLOWING OPERATIONS AVAILABLE: (S) RECEIPT MATERIALS: (T) ENVIRONMENTAL MONITORING:
  • 25.
    © 2007 Centerfor Pharmaceutical Learning (U) INTERNAL LABELLING , QUARANTINE AND STORAGE OF MATERIALS: (V) EACH INSTRUMENT AND EQUIPMENT IN THEIR PREXIMITY: (W)EQUIPMENT ASSEMBLY AND VALIDATION: (X) SAMPLING(RAW MATERIALS AND FINISHED PRODUCTS): (Y) DISPENSING (RAW MATERIALS AND PACKING MATERIALS): (Z) BATCH NUMBERING SYSTEM: (AA)RELEASE OR REJECTION: (BB)LOG BOOK FOR EACH EQUOPMENT AND INSTRUMENT: (CC)SANITATION AND CLEANING OF PREMISES AND EQUIPMENT: (DD)SANITATION OF PIPES CARRYING DISTILLED/DEIONISED WATER:
  • 26.
    © 2007 Centerfor Pharmaceutical Learning (EE)RECOVERY FROM REJECTED PRODUCTS: (FF)DISPOSAL/REUSE OF RETURNED GOODS: (GG)PEST CONTROL: (HH)ANALYTICAL APPARATUS AND CALIBRATION: (II) COMPLAINTS,RECALLS AND RETURNS: (JJ) COMPARE SOPs WITH ACTUAL PRACTICE: 11. PRODUCTION: 9.1 IS THERE ANY DEVIATION FROM SOPs MANUFACTURING PROCEDURES: 9.2 IS YIELD CHECKED AT EACH STAGE: 9.3 IS MORE THAN ONE PRODUCT PROCESSED IN THE SAME ROOM: 9.4 ARE EQUIPMENTS AND ROOMS LABELLED TO INDICATE THE OPERATION IN PROGRESS: 9.5 IS ANY NON MEDICAL PRODUCT PRODUCED. SPECIFY THE DETAILS: 9.6 IS THERE PROVISION FOR INPROCESS CONTROLS IN THE PRODUCTION AREA(MUST NOT EFFECT THE QUALITY OF THE PRIODUCTS MANUFACTURED): 9.7 IS THERE PROVISION FOR
  • 27.
    © 2007 Centerfor Pharmaceutical Learning DUST COLLECTION WHERE DRY MATERIALS ARE HANDLED: 9.8 IS PERIODICAL MICROBIAL MONITORING OF PRODUCTION AREAS OF SUCEPTIBLE PRODUCTS CONDUCTED: 9.9 WAS THE AREA BEING CLEANED BEFORE STARTING EVERY BATCH: 9.10 ARE PIPES CARRYING DISTILLED/DEIONISED WATER SANITIZED ACCORDING TO PROCEDURE WHICH INDICATE LIMITS FOR MICROBIAL CONTAMINATION AND MEASURES TO BE TAKEN: 9.11 WAS ANY BATCH REPROCESSED FROM REJECTED PRODUCTS: 9.12 WAS ANY BATCH RETURNED HAS BEEN CONVERTED FOR RESALE , RELABELLING OR BULKING: 12. PACKAGING: 10.1 IS THERE ADEQUATE SEPARATION OF PACKING LINES TO PREVENT ANY MIX- UP: 10.2 IS EACH PACKAGING LINE IDENTIFIED WITH PRODUCT NAME, BATCH NO. AND PACKAGING SIZE: 10.3 IS ONLY ONE PRODUCT, BATCH AND PACKAGING SIZE ON A LINE AT ANY GIVEN TIME: 10.4 IS LINE CLEARED BEFORE EACH BATCH OPERATION,CERTIFIED AND RECORDED: 10.5 DOES PACKING QUICKLY
  • 28.
    © 2007 Centerfor Pharmaceutical Learning FOLLOWS THE FILLING AND SEALING: 10.6 ARE ALL CODED PACKING MATERIALS VERIFIED BEFORE USE. 10.7 IS RECONCILATION OF PACKING MATERIALS USED VIS-À-VIS PRODUCT RECORDED: 10.8 IS ON LINE COTROL PROCEDURE DURING PACKING AVAILABLE: 13. QUALITY CONTROL: 11.1 HOW FAR THE HEAD OF QUALITY CONTROL AND PRODUCTION ARE INDEPENDENT OF EACH OTHER: 11.2 ARE ALL THE PROCEDURES OF DOCUMEBNTED: 11.3 IS SAMPLING PROCEDURE ADEQUATE: 11.4 DO THE LABEL ON SAMPLE CONTAINER, SHOW BATCH NO. , NAME,CONTAINER NO., DATE OF SAMPLING AND PERSON WHO SAMPLED: 11.5 IS IDENTIFY TEST DONE ON EACH CONTAINER OF STARTING MATERIALS: 11.6 ARE ANALYTICAL RECORDS OF EACH BATCH OF THE RAW MATERIALS,INTERMEDIATES AND FINISHED PRODUCTS AVAILABLE WITH WORK SHEETS: 11.7 ARE PRODUCTION RECORDS REVIEWED: 11.8 ARE ALL RETENTION SAMPLES KEPT FOR ONE YEAR AFTER EXPIRY DATE AND OTHER
  • 29.
    © 2007 Centerfor Pharmaceutical Learning STARTING MATERIALS FOR A MINIMUM OF TWO YEARS: 11.9 IS PROGRAMME FOR STABILITY TESTING OF STARTING MATERIALS AND FINISHED PRODUCTS AVAILABLE: 11.10 IS STABILITY TESTING CONDUCTED PRIOR TO MARKETING AND AFTER CHANGE OF PROCESS EQUIPMENT,PACKING MATERIALS: 11.11 IS QUALITY CONTROL LAB SEPARATE FROM PRODUCTION AREA: 11.12 ARE BIOLOGICAL AND MICROBIOLOGICAL TESTING AREAS SEPARATE FROM EACH OTHER,AND DO THEY HAVE SEPARATE AIR HANDLING FACILITIES: 11.13 IS INSTRUMENT ROOM SEPARATE: 11.14 IS DESIGN OF LAB SUITABLE WITH ADEQUATE SPACE,VENTILATION AND FOR PREVENTION OF FUMES: 11.15 ARE RECORDS OF SERVICE AND CALIBRATION OF INSTRUMENT AVAILABLE: 11.16 ARE APPROPRIATE SAMPLING EQUIPMENT AVAILABLE AND STARTED SEPARATELY: 11.17 ARE INSTRUMENTS CHECKED DAILY OR PRIOR TO USE: 11.18 ARE DATE OF CALIBRATION , SERVICE ,AND DATE WHEN RECALIBRATION DUE INDICATED: 11.19 ARE THE REAGENTS PREPARED ACCORDING TO WRITTEN PROCEDURES AND LABELLED APPROPRIATELY:
  • 30.
    © 2007 Centerfor Pharmaceutical Learning 11.20 ARE REFERENCE STANDARDS AVAILABLE CORRESPOND TO THE MATERIALS ANALYSED: 11.21 IS ADEQUATE STORAGE SPACE (IF NECESSARY WITH COOLING) AND RECORDS ARE AVAILABLE FOR REFERENCE STANDARDS AND REFERENCE SAMPLES. CHECK THE MODE OF STORAGE OF REFERENCE STANDARDS: 11.22 ARE WORKING STANDARDS CHECKED AT REGULAR INTERVALS: 11.23 ARE THE LABELS OF REF. STANDARDS INDICATE NAME, DATE OF MFG. DATE OF EXPIRY,CONCENTRATION AND DATE OF CLOSURE IS FIRST OPENED AND STORAGE CONDITIONS: 11.24 ARE THE LABEL OF REAGENTS PREPARED SHOW CONCENTRATION , STANDARDISATION FACTOR, SELF- LIFE,STANDARDISATION DATE ,STORAGE CONDITION AND SIGNATURE OF THE PERSON PREPARES THE REAGENTS: 11.25 ARE POSITIVE AND NEGATIVE CONTROLS USED TO TEST SUITABILITY OF CULTURE MEDIA: 11.26 ARE STABILITY STUDIES CONDUCTED BEFORE ASSIGNING SHELF LIFE AND IS IT PERIODICALL REVIEWED, AND GIVE DETAILS: 14. SELF INSPECTION:
  • 31.
    © 2007 Centerfor Pharmaceutical Learning GIVE DETAILS OF NAMES, QUALIFICATION AND BACKGROUND OF THE MEMBERS OF SELF INSPECTION TEAM: 12.1 INTERVAL PERIOD BETWEEN SELF INSPECTIONS: 12.2 DOES SELF INSPECTION REPORT CONTAINS COMMENTS ON: (P) PERSONNEL: (Q) PREMISES: (R) MAINTENANCE OF BUILDING AND EQUIPMENT: (S) STORAGE: (T) EQUIPMENT: (U) PRODUCTION AND INPROCESS CONTROL: (V) QUALITY CONTROL: (W)DOCUMENTATION: (X) SANITATION AND HYGIENE: (Y) VALIDATION PROCEDURE / PROGRAMMES: (Z) CALIBRATION OF INSTRUMENTS:
  • 32.
    © 2007 Centerfor Pharmaceutical Learning (AA)RECALL PROCEDURES: (BB)LABELS CONTROL: (CC)COMPLAINTS: (DD)CORRECTIVE ACTION ON PREVIOUS REPORTS: 13. RECALL PROCEDURE : EXPLAIN PROCEDURE ADOPTED FOR RECALL OF PRODUCTS: 14. QUALITY AUDIT SYSTEM : (BRIEF RESPONSIBILITIES)
  • 33.
    © 2007 Centerfor Pharmaceutical Learning REMARKS: